Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Aeromedical, Aerospace, Air, ALiVe, Aloni, appeal, appealed, Appyea, Arazim, Article, Arye, ASD, authoritative, Basedsolely, BATM, BBA, begun, beverage, bid, Bipartisan, blind, Blueprint, branch, bridge, BVC, Cadillac, cannabimimetic, CannAmide, CanPharma, cardiovascular, Carnie, cellular, clarification, Cleveland, Col, contest, CPTP, crucial, Cum, cut, Danville, deadline, deconsolidated, Deconsolidation, donut, dossier, Dublin, easy, eleven, excellence, familiarity, fault, FCCP, fellow, female, fight, flumazenil, forgoing, gap, Geisinger, Gilad, greatest, Gurion, Hashomer, headquartered, Heavenly, hemp, HHS, hole, Hospice, House, hypnotic, implanted, incentivize, infused, inpatient, inseverable, instilled, Invantek, ITCI, judgement, Kharkiv, Kitov, KTOV, largest, Laude, Lecturer, Lerner, Lev, LIA, lifted, living, loosen, LSE, MASCC, Meitar, Mellar, microvascular, Mizrachi, modification, multitude, Navy, network, NNHPD, nondeductible, Northern, Nottingham, nutritional, occasionally, outlook, PA, palliative, pandemic, PC, pet, PhD, pocket, poverty, Presidential, promissory, properly, Pure, pursuit, raw, reengaged, regain, regained, regaining, reimplemented, remotely, resale, Respectrum, Ret, run, Rx, Saint, Saoirse, scarcer, Scholarship, Scorpio, sector, sentiment, SNCM, solubility, span, spread, spreading, SPRTN, Star, strain, sublease, Summa, Sunny, supposedly, Surgeon, Taussig, Tefahot, Tide, Todd, tolling, topic, totheTASE, Trinity, Ukraine, unified, unprecedented, vacancy, versa, Violette, Viollete, volunteer, Webber, Weber, West, Western, workforce, Wuhan
Removed:
adjudication, agenda, aggregating, aim, alteration, Alvarion, Ami, analog, anesthesia, announcing, antibacterial, antibiotic, antimicrobial, asserted, assisting, attaching, attend, attending, Azrieli, Bachelor, bacteria, bacterial, bargain, BBS, Belvit, Benjamin, bestow, Biopharmaceutical, Biosonix, broaden, built, cancel, cell, CEO, CFO, chronically, COMP, consolidate, constrain, convening, convert, Copaxone, Corning, counsel, counting, Dash, decreased, dedicated, designer, digit, divide, Dolphin, Doron, efficiency, Elran, enhance, enhanced, enlargement, entirety, entitling, examination, existence, falsity, father, favorably, fit, formally, Foxcom, freely, Goldin, Green, Guy, Haber, Hamashbir, il, Ilan, incorporating, intragroup, Itay, Jay, Jesselson, Kodak, Lastly, launch, lesser, lessor, LLC, LLP, locate, MATIMOP, medial, Mega, metal, Micha, misrepresentation, Momentum, nasal, nasvax, Navidea, necessity, Neoprobe, nominal, objective, objectively, occurring, Orex, OTC, overlap, paradigm, Parliament, partnering, path, Pathology, percent, physiological, pioneer, PK, Polar, preemptive, probationary, producer, prosecuted, purposed, quickly, Radiography, receivership, reelected, reliably, removal, resign, resistance, reversal, reverse, reversed, Roth, Shoe, situated, slightly, Spuntech, stand, step, stimulate, subdivide, summoned, supervise, Supreme, Survey, survive, sweeping, synergistic, Tefen, tendered, tenet, tenure, Teva, Thera, THXBY, turnaround, unchanged, underwriting, upheld, uptake, urgent, warranty, week, Weizmann
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2 Description of Securities
- 4.8 First Amendment to License Agreement Dated As of August 19, 2015, by and Between the Company and Dekel Pharmaceuticals LTD.
- 4.9 Third Amendment to License Agreement Dated As of July 14, 2019, by and Between the Company and Dekel Pharmaceuticals LTD.
- 8.1 List of Subsidiaries
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Kost, Forer, Gabbay & Kasierer,a Member of Ey Global
- Download Excel data file
- View Excel data file
SPRC similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350
In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2019 (the “Report”) by Therapix Biosciences Ltd. (the “Company”), the undersigned, as Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 15, 2020 | /s/ Oz Adler |
Oz Adler | |
Chief Financial Officer |